India Inc deal value drops 80% in February

User Rating

Total value of deals involving Indian companies plunged 80 per cent year-on-year in February, although experts said the momentum will gather pace soon spurred mainly by aviation, media, retail and pharma sectors.

This represents a drastic decline of nearly 80.58 per cent from the year ago period, when the deal tally stood at a whopping $15.45 billion.

“With the 2013 budget being done and Government’s focus to control fiscal deficit and bring back growth, we expect deal momentum to pick up in 2013 hopefully with cross-border action coming back in sectors like aviation, media, retail, pharma etc,” Grant Thornton India Partner, Transaction Advisory Services Raja Lahiri said.

In February, inbound deals, wherein foreign firms or their subsidiaries acquired Indian entities, there was $1.99 billion worth of deals through 7 transactions as compared to $0.27 billion by way of 9 deals in the corresponding month of 2012.

In February 2013, the total value of outbound deals, where Indian companies acquire businesses outside India, stood at just $0.07 billion through 4 deals as compared to $0.44 billion via 5 deals during the year ago period.

Value of PE deals amounted to $0.30 billion (29 deals) in February 2013 as compared to $0.70 billion (45 deals) in the same month last year.

US generic drug maker Mylan’s $1.8 billion buy out of the drug injectible business of Bangalore-based firm Strides Arcolab was the deal of the month, followed by Webhelp SA’s acquisition of HEROtsc from the Hero Group for a total consideration of $123 million.

Other major deals during the month were Varun Beverages’ acquisition of Pearl Drinks-Bottling business for $73 million, Bharat Light & Power’s buyout of DLF’s wind turbine business in Gujarat for $51 million and Thomas Cook India’s 74 per cent stake acquisition in IKYA Human Capital Solutions for $47 million.

Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in the healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry.